SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
赵旭东
Lv1
1
60 积分
2022-07-26 加入
最近求助
最近应助
互助留言
Mind the GAP(43) for mitochondria transfer to glioblastomas
2小时前
已完结
Long-term Survival, Quality of Life, and Molecular Features of the Patients With Solid Pseudopapillary Neoplasm of the Pancreas
11天前
已完结
Mitochondrial swap from cancer to immune cells thwarts anti-tumour defences
24天前
已完结
Immunotherapy for Recurrent and Metastatic Cervical Cancer: A Review
1个月前
已完结
Preoperative endoscopic pancreatic stenting for prophylaxis of pancreatic duct disruption during extirpation of a pancreatic head tumor
8个月前
已完结
自身免疫性胰腺炎诊治进展
9个月前
已完结
A targetable secreted neural protein drives pancreatic cancer metastatic colonization and HIF1a nuclear retention
1年前
已完结
Abstract CT031: A pilot clinical trial of neoadjuvant modified FOLFIRINOX plus nivolumab in borderline resectable pancreas cancer
1年前
已完结
A multicenter, randomized phase II study of total neoadjuvant therapy (TNT) with FOLFIRINOX (FFX) and SBRT, with or without losartan (L) and nivolumab (N) in borderline resectable (BR) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC)
1年前
已完结
Efficacy and safety of neoadjuvant therapy with stereotactic body radiation therapy followed by nab-paclitaxel/gemcitabine plus camrelizumab for resectable, borderline resectable and locally advanced pancreatic cancer: Preliminary results
1年前
已完结
没有进行任何应助
作者是武家豪 发布于中国实用外科杂志
9个月前
感谢
1年前
点赞
1年前
感谢
3年前
感谢,感谢,感谢
3年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论